Patents by Inventor Beat Schmitz

Beat Schmitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9573928
    Abstract: The present invention relates to novel amides and a process for preparing these amides.
    Type: Grant
    Filed: September 30, 2014
    Date of Patent: February 21, 2017
    Assignee: Novartis AG
    Inventors: Olivier Loiseleur, Daniel Kaufmann, Stephan Abel, Hans Michael Bürger, Mark Meisenbach, Beat Schmitz, Gottfried Sedelmeier
  • Publication number: 20150018552
    Abstract: The present invention relates to novel amides and a process for preparing these amides.
    Type: Application
    Filed: September 30, 2014
    Publication date: January 15, 2015
    Applicant: Novartis AG
    Inventors: Olivier Loiseleur, Daniel Kaufmann, Stephan Abel, Hans Michael Bürger, Mark Meisenbach, Beat Schmitz, Gottfried Sedelmeier
  • Publication number: 20120226039
    Abstract: The present invention relates to novel amides and a process for preparing these amides.
    Type: Application
    Filed: May 17, 2012
    Publication date: September 6, 2012
    Inventors: Olivier Loiseleur, Daniel Kaufmann, Stephan Abel, Hans Michael Bürger, Mark Meisenbach, Beat Schmitz, Gottfried Sedelmeier
  • Patent number: 8084487
    Abstract: The present invention relates to a process for the production of carbamic acid (2-chloroethyl)(3-oxocyclohexyl)-alkyl ester enantiomers and of 1-carbalkoxy-4-ketoperhydroindole enantiomers.
    Type: Grant
    Filed: August 10, 2009
    Date of Patent: December 27, 2011
    Assignee: Novartis AG
    Inventors: Ernst Kuesters, Murat Acemoglu, Philipp Lustenberger, Gottfried Sedelmeier, Beat Schmitz, Gerhard Penn
  • Publication number: 20110144352
    Abstract: The present invention relates to a process for the production of carbamic acid (2-chloroethyl)(3-oxocyclohexyl)-alkyl ester enantiomers and of 1-carbalkoxy-4-ketoperhydroindole enantiomers.
    Type: Application
    Filed: August 10, 2009
    Publication date: June 16, 2011
    Applicant: NOVARTIS AG
    Inventors: Ernst Kuesters, Murat Acemoglu, Philipp Lustenberger, Gottfried Sedelmeier, Beat Schmitz, Gerhard Penn
  • Patent number: 7825247
    Abstract: The present invention relates to novel amides and a process for preparing these amides.
    Type: Grant
    Filed: August 28, 2007
    Date of Patent: November 2, 2010
    Assignee: Novartis AG
    Inventors: Olivier Loiseleur, Daniel Kaufmann, Stephan Abel, Hans Michael Bürger, Mark Meisenbach, Beat Schmitz, Gottfried Sedelmeier
  • Patent number: 7816359
    Abstract: The present invention relates to novel amides and a process for preparing these amides.
    Type: Grant
    Filed: August 28, 2007
    Date of Patent: October 19, 2010
    Assignee: Novartis AG
    Inventors: Olivier Loiseleur, Daniel Kaufmann, Stephan Abel, Hans Michael Bürger, Mark Meisenbach, Beat Schmitz, Gottfried Sedelmeier
  • Patent number: 7579467
    Abstract: The present invention relates to novel amides and a process for preparing these amides.
    Type: Grant
    Filed: August 28, 2007
    Date of Patent: August 25, 2009
    Assignee: Novartis AG
    Inventors: Olivier Loiseleur, Daniel Kaufmann, Stephan Abel, Hans Michael Bürger, Mark Meisenbach, Beat Schmitz, Gottfried Sedelmeier
  • Publication number: 20090137805
    Abstract: The present invention relates to novel amides and a process for preparing these amides.
    Type: Application
    Filed: February 2, 2009
    Publication date: May 28, 2009
    Inventors: Olivier Loiseleur, Daniel Kaufmann, Stephan Abel, Hans Michael Burger, Mark Meisenbach, Beat Schmitz, Gottfried Sedelmeier
  • Publication number: 20090018325
    Abstract: A novel method has been found to produce 2,2?-anhydro-1-(?-L-arabinofuranosyl)thymine as a novel useful intermediate compound. A novel method has been further found to produce thymidine from 2,2?-anhydro-1-(?-L-arabinofuranosyl)thymine. According to these methods, synthesis of various L-nucleic acid derivatives, synthesis of which has been difficult till now, is possible.
    Type: Application
    Filed: March 15, 2007
    Publication date: January 15, 2009
    Inventors: Jacques Cercus, Michael Foulkes, Thomas Heinz, Daniel Niederer, Beat Schmitz
  • Patent number: 7456283
    Abstract: The present invention relates to novel amides and a process for preparing these amides.
    Type: Grant
    Filed: February 6, 2003
    Date of Patent: November 25, 2008
    Assignee: Novartis AG
    Inventors: Olivier Loiseleur, Daniel Kaufmann, Stephan Abel, Hans Michael Bürger, Mark Meisenbach, Beat Schmitz, Gottfried Sedelmeier
  • Publication number: 20070293673
    Abstract: The present invention relates to novel amides and a process for preparing these amides.
    Type: Application
    Filed: August 28, 2007
    Publication date: December 20, 2007
    Inventors: Olivier Loiseleur, Daniel Kaufmann, Stephan Abel, Hans Burger, Mark Meisenbach, Beat Schmitz, Gottfried Sedelmeier
  • Publication number: 20070293683
    Abstract: The present invention relates to novel amides and a process for preparing these amides.
    Type: Application
    Filed: August 28, 2007
    Publication date: December 20, 2007
    Inventors: Olivier Loiseleur, Daniel Kaufmann, Stephan Abel, Hans Burger, Mark Meisenbach, Beat Schmitz, Gottfried Sedelmeier
  • Publication number: 20070293504
    Abstract: The present invention relates to novel amides and a process for preparing these amides.
    Type: Application
    Filed: August 28, 2007
    Publication date: December 20, 2007
    Inventors: Olivier Loiseleur, Daniel Kaufmann, Stephan Abel, Hans Burger, Mark Meisenbach, Beat Schmitz, Gottfried Sedelmeier
  • Publication number: 20070293672
    Abstract: The present invention relates to novel amides and a process for preparing these amides.
    Type: Application
    Filed: August 28, 2007
    Publication date: December 20, 2007
    Inventors: Olivier Loiseleur, Daniel Kaufmann, Stephan Abel, Hans Burger, Mark Meisenbach, Beat Schmitz, Gottfried Sedelmeier
  • Publication number: 20060142580
    Abstract: The present invention relates to novel amides and a process for preparing these amides.
    Type: Application
    Filed: February 6, 2003
    Publication date: June 29, 2006
    Inventors: Olivier Loiseleur, Daniel Kaufmann, Stephan Abel, Hans Burger, Mark Meisenbach, Beat Schmitz, Gottfried Sedelmeier
  • Publication number: 20050118101
    Abstract: The present invention relates to a conjugate that comprises a) at least one compound to be delivered into or across a biological carrier, b) a delivery-enhancing transporter comprising at least 4 ?-homolysine residues, especially between 4 and 25 ?-homolysine residues, c) optionally a linker between the components a) and b), and d) optionally a labelling unit; to the salts of such conjugates; to a pharmaceutical composition comprising said conjugate; to a method for delivery of a compound into or across a biological barrier, the method comprising contacting the barrier with said conjugate; and to a process for the preparation of certain conjugates.
    Type: Application
    Filed: January 27, 2003
    Publication date: June 2, 2005
    Inventors: Olivier Loiseleur, Daniel Kaufmann, Stephan Abel, Hans-Michael Burger, Mark Meisenbach, Beat Schmitz, Gottfried Sedelmeier
  • Patent number: 4711880
    Abstract: The invention relates to a novel crystal modification, containing water of crystallization, of disodium 3-amino-1-hydroxypropane-1,1-diphosphonate of the formula ##STR1## and to a process for the manufacture thereof. This modification is suitable for the oral treatment of disorders of the calcium and phosphate metabolism and associated diseases in warm-blooded animals.
    Type: Grant
    Filed: September 8, 1986
    Date of Patent: December 8, 1987
    Assignees: Ciba-Geigy Corporation, Henkel Kommanditgesellschaft auf Aktien
    Inventors: Peter H. Stahl, Beat Schmitz
  • Patent number: 4639338
    Abstract: The invention relates to a novel crystal modification, containing water of crystallization, of disodium 3-amino-1-hydroxypropane-1,1-diphosphonate of the formula ##STR1## and to a process for the manufacture thereof. This modification is suitable for the oral treatment of disorders of the calcium and phosphate metabolism and associated diseases in warm-blooded animals.
    Type: Grant
    Filed: July 29, 1985
    Date of Patent: January 27, 1987
    Assignees: Ciba-Geigy Corporation, Henkel Kommanditgesellschaft auf Aktien
    Inventors: Peter H. Stahl, Beat Schmitz